when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

TECVAYLI (TECLISTAMAB-CQYV) — FDA approval

August 9, 2023teclistamabupdated 5mo ago

community read0 votes

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalMar 5, 2026 · 213d ago
approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalOct 2, 2025 · 367d ago
approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalAug 19, 2025 · 411d ago
approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalDec 2, 2024 · 671d ago
approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalNov 22, 2024 · 681d ago
approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalJul 2, 2024 · 824d ago
approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalMay 28, 2024 · 859d ago
approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalFeb 20, 2024 · 957d ago

same company · ±60 days · 3

approvaltalquetamab: TALVEY (TALQUETAMAB-TGVS) — FDA approvalAug 9, 2023
approval(abiraterone acetate + niraparib): AKEEGA (ABIRATERONE ACETATE) — FDA approvalAug 11, 2023
approvalguselkumab: TREMFYA (GUSELKUMAB) — FDA approvalJun 29, 2023

🐶 often sniffed alongside

top 3

drugTECVAYLI44 co-mentions · 11 sources
tagApproval44 co-mentions · 11 sources
companyJanssen Biotech Inc22 co-mentions · 11 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?